Skye Bioscience, Inc.SKYENASDAQ
Loading
Cash Flow PerformanceCompressed
Percentile Rank0
Studio
Year-over-Year Change

Free cash flow yield

Latest
-144.84%
↓ 119% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineCompressed
Average
-66.13%
Historical baseline
PeriodValueYoY Change
2025-144.84%-457.2%
2024-25.99%+64.5%
2023-73.28%+49.0%
2022-143.76%-362.9%
2021-31.05%+52.7%
2020-65.67%-89.8%
2019-34.60%-360.8%
2018-7.51%+89.6%
2017-72.30%-16.1%
2016-62.29%-